Come up with a name for your new list and we'll add to it:
Spero Therapeutics raised a round of funding on May 05, 2017. Investors include
National Institutes of Health.
Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a novel and highly differentiated pipeline of antibacterials focused on unmet needs of patie…